Form 4 for CRL Charles River Laboratories
Accepted 2023-05-31 00:00:00 ET · period of report 2023-05-26 · accession 0001127602-23-017131 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-05-31 | 2023-05-27+ | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | F - Tax | $194.12 | -286 | 7,469 | -4% | -$55.5K |
| D | 2023-05-31 | 2023-05-26 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | A - Grant | $0.00 | +1,700 | 7,574 | +29% | $0 |
| D | 2023-05-31 | 2023-05-26 | CRL | Parisotto Shannon M | CEVP, Disc, Safety Assessment | A - Grant | $194.12 | +4,078 | 4,078 | New | +$791.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-29 | F | D | 110 | $194.12 | 7,288 | D | — | — | |
| 2 | Common | Common Stock | 2023-05-28 | F | D | 71 | $194.12 | 7,398 | D | — | — | |
| 3 | Common | Common Stock | 2023-05-27 | F | D | 105 | $194.12 | 7,469 | D | — | — | |
| 4 | Common | Common Stock | 2023-05-26 | A | A | 1,700 | $0.00 | 7,574 | D | — | — | (F1) Restricted Stock Units vest as follows: 425 on May 26, 2024, 425 on May 26, 2025, 425 on May 26, 2026 and 425 on May 26, 2027. |
| 5 | Derivative | Stock Options (Right to Buy) | 2023-05-26 | A | A | 4,078 | $194.12 | 4,078 | D | $194.12 · 2024-05-26 to 2033-05-26 | 4,078 Common Stock | (F2) Stock Options vest as follows: 1,019 on May 26, 2024, 1,020 on May 26, 2025, 1,019 on May 26, 2026 and 1,020 on May 26, 2027. |